Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
60.14
-2.14 (-3.44%)
At close: Jun 5, 2026, 4:00 PM EDT
60.00
-0.14 (-0.23%)
After-hours: Jun 5, 2026, 6:40 PM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $3.63 billion as of June 5, 2026. Its market cap has increased by 812.22% in one year.
Market Cap
3.63B
Enterprise Value
3.13B
1-Year Change
812.22%
Ranking
Category
Stock Price
$60.14
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $3.63B, an increase of 327.07%. That is a compound annual growth rate of 127.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 3.76B | 156.00% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 4.29B |
| Veradermics | 4.23B |
| Erasca | 4.13B |
| Edgewise Therapeutics | 4.01B |
| Catalyst Pharmaceuticals | 3.83B |
| NewAmsterdam Pharma Company | 3.82B |
| ACADIA Pharmaceuticals | 3.72B |
| Crinetics Pharmaceuticals | 3.65B |